|
Circulating Rare Cells at HandScreenCell® innovative technology enables easy, rapid, and open access to Circulating Rare Cells in peripheral blood |
- February 13, 2013 - ScreenCell sponsors TriCON 2013 from Feb 13-15 in San Francisco
- January 15, 2013 - Paris – ScreenCell today released a white paper that details a “next generation” technology for fast isolation of undamaged fixed cells and viable live circulating tumor cells
- July 9, 2012 - ScreenCell and BioView Announce Worldwide Commercial Collaboration Agreement for Circulating Tumor Cell (CTC) Technology
- May 17, 2012 - Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology
- November 8, 2011 - Transgenomic and ScreenCell Announce Worldwide Distribution and Collaboration Agreement for Circulating Tumor Cell (CTC) Technology